CRISPR/Cas9-Mediated Reprogramming of Medicinal Plants for Enhanced Anti-Cancer Bioactive Compounds “Advances in Genome Editing for Plant-Derived Therapeutics”. Journal of Carcinogenesis, [S. l.], v. 24, n. 3, p. 733–739, 2024. DOI: 10.64149/J.Carcinog.24.3.350-356. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/805. Acesso em: 14 mar. 2026.